Company Number: 14594230

Analysis Date: 2025-07-29 14:26 UTC

Financial Health Assessment for INFUSED JARS LTD

---

1. Financial Health Score: F

Explanation:
INFUSED JARS LTD exhibits critical financial distress as evidenced by negative net current assets and net assets, indicating the company is currently insolvent on a balance sheet basis. This is a severe symptom of financial ill-health, warranting urgent remedial action.

---

2. Key Vital Signs

Metric	Value (£)	Interpretation
Fixed Assets	333	Minimal investment in long-term assets, typical for a micro entity.
Current Assets	572	Very low liquid resources available to meet immediate obligations.
Current Liabilities	3,826	Significant short-term debts due within one year.
Net Current Assets	-3,254	Negative working capital ("liquidity deficit"), a major red flag.
Total Assets Less Current Liabilities	-2,921	Indicates overall liabilities exceed assets, showing insolvency.
Net Assets	-2,921	Negative equity; shareholders' funds are eroded.

Interpretation:
The "vital signs" here reveal that INFUSED JARS LTD is exhibiting symptoms akin to a patient with a severe liquidity crisis and balance sheet insolvency. The company owes substantially more in short-term liabilities than it holds in current assets, meaning it may struggle to pay suppliers, creditors, or meet other financial obligations as they fall due.

---

3. Diagnosis

INFUSED JARS LTD is in a precarious financial position. The negative net current assets and net assets indicate the company is technically insolvent. This is a critical symptom of financial distress, implying either accumulated losses or undercapitalization since inception (the company was incorporated in January 2023). No employees have been reported, suggesting a very early-stage or dormant operational status, or that the business is not yet generating meaningful revenues.

The company's micro-entity status limits the scope and complexity of its reporting, but the available balance sheet clearly signals financial strain. Without sufficient cash or receivables to meet liabilities, liquidity risk is acute. The directors must be vigilant to avoid wrongful trading and consider restructuring or capital injection.

---

4. Recommendations

Immediate Actions to Stabilize Financial Health:

1. Address Liquidity Deficit:

   • Inject fresh equity or secure short-term financing to cover immediate liabilities and restore positive working capital.
   • Negotiate extended payment terms with creditors to relieve short-term cash flow pressure.

2. Financial Planning and Forecasting:

   • Prepare detailed cash flow forecasts to monitor liquidity needs and identify funding gaps early.
   • Implement strict cash management controls to conserve available resources.

3. Operational Review:

   • Assess the business model viability given current financial constraints.
   • Explore cost reduction measures; employing staff may need to be delayed or minimized until finances improve.

4. Director Responsibilities:

   • Directors should seek professional advice to understand their fiduciary duties under insolvency law.
   • Consider whether the company can continue as a going concern or if formal insolvency procedures are necessary.

5. Strategic Considerations:

   • Explore potential for external investment or loans from related parties.
   • Evaluate market opportunities to generate revenue quickly and improve asset base.

---

Medical Analogy Summary

INFUSED JARS LTD is currently exhibiting "symptoms of severe financial distress" akin to a patient with critical organ failure—specifically liquidity and solvency failures. The company is in a state of "financial shock" with negative net assets indicating it is "underweight" in capital and unable to meet immediate obligations. Without urgent intervention—such as capital infusion or restructuring—the prognosis is poor.

---